BackWerewolf Therapeutics Overview

Werewolf Therapeutics Current Cash

Track Werewolf Therapeutics's current cash ($22M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$21.99M
71.99% YoYΔ $-56.50M vs prior year quarter

Peer trimmed avg / median

Loading

Werewolf Therapeutics Current Cash History

Loading

Werewolf Therapeutics vs. peers: Current Cash Comparison

Loading

Werewolf Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Werewolf Therapeutics (HOWL) FAQ

Werewolf Therapeutics (HOWL) currently reports a current cash of $22M as of June 2026. That compares with $78M in the prior-year period — down 72.0% year over year. Use the charts on this page to explore Werewolf Therapeutics's current cash history and peer comparisons.

Werewolf Therapeutics's current cash decreased from $78M to $22M — a 72.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Werewolf Therapeutics reported $22M in current cash as of June 2026. That compares with $78M in the prior-year period — down 72.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $22M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Werewolf Therapeutics, and consider following HOWL for alerts when major investors trade the stock.

Werewolf Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $22M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HOWL with unrelated industries.